Soha Ahmad, MD
Interventional Cardiology · Los Angeles
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 18 years
- Georgetown University School of Medicine, 2008
Offices
1 location
Hospitals listed: Hollywood Presbyterian Medical Center · Huntington Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ahmad’s office at (323) 448-0334 to ask if they take your plan before you enroll.
State licence records
1 licence
- Washington MD.MD.60640196Physician And Surgeon License · since 2016 · expires 2022-08-01ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Hollywood Presbyterian Medical CenterLos Angeles, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.016, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.165, Oct 2024 – Sep 2025
- Huntington HospitalPasadena, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Cedars Sinai Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 76% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for Hollywood Presbyterian Medical Center
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 1 better, 5 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.016 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.165 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0 to 1.95) · 687 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.51 to 1.21) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 140.36 (84.45 to 196.27) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 77 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.7 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.5 · 289 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.7 · 93 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 1,577 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 3,875 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,998 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.09 (1.83 to 6.36) · 761 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0 to 3.29) · 396 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.67 to 3.87) · 834 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.18 (0 to 14.44) · 416 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.49 (1.39 to 9.58) · 287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.18 to 3.18) · 172 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.36 (0 to 1.04) · 3,450 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 209 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.363 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.8 · 124 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 304 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -17.4 · 79 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 22.2 · 231 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 40.9 · 284 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 331 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 106 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.3 to 16.8) · 72 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,225 patients answered, 24% of those asked)
| Cleanliness | 2 |
| Nurse communication | 1 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 66% |
| Doctors "always" communicated well | 69% |
| Staff "always" explained | 50% |
| Yes, staff "did" give patients this information | 79% |
| Yes, staff "did" give patients information about help after discharge | 75% |
| Doctors "always" explained things so they could understand | 64% |
| Doctors "always" listened carefully | 67% |
| Doctors "always" treated them with courtesy and respect | 75% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 66% |
| Nurses "always" explained things so they could understand | 62% |
| Nurses "always" listened carefully | 63% |
| Nurses "always" treated them with courtesy and respect | 73% |
| "Always" quiet at night | 40% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 35% |
| Yes, staff "did" give patients information about possible symptoms | 82% |
See every measure and the patient survey for Huntington Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 1 better, 6 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.68 (0 to 1.56) · 2,225 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.63 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 149.43 (106.58 to 192.28) · 128 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 67 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 112 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 8.8 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 475 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.7 · 822 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 463 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 5,850 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.36) · 10,123 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.07 to 0.43) · 10,515 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.4 (2.67 to 6.13) · 2,613 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.32 (0 to 2.86) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.77 (1.44 to 4.11) · 2,457 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.71 (1.95 to 13.48) · 1,211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.08 (0.8 to 7.36) · 1,189 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.85 (0.42 to 3.29) · 825 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0.03 to 1.09) · 8,956 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 269 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.448 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.977 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.423 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 253 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.9 · 846 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 5.2 · 176 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.1 · 542 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 9.5 · 864 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 1,144 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.2 to 8.5) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (6.9 to 15.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 260 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.1 · 87 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 201 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.8 (8.8 to 15.8) · 365 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1) · 786 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,430 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$139,566
Medicare paid this office $139,566 for 1,273 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 227 | $32,028 | $141 |
| Return visit (30+ min) | 173 | $29,946 | $105 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 289 | $17,118 | $56 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 90 | $15,983 | $172 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $6,536 | $98 |
See all 12 services
| New patient visit (45+ min) | 227 | $32,028 | $141 |
| Return visit (30+ min) | 173 | $29,946 | $105 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 289 | $17,118 | $56 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 90 | $15,983 | $172 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $6,536 | $98 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 764 | $6,063 | $7 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,555 | $142 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 259 | $3,289 | $12 |
| Programming of dual lead pacemaker system | 22 | $1,496 | $68 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 12 | $806 | $58 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 12 | $784 | $60 |
| Insertion of needle into vein for collection of blood sample | 59 | $554 | $9 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 13 | More than 34% of doctors who do this |
Who their Medicare patients are
1,273 Original Medicare patients in 2024. Average age 76 · Under 65 9% · 85 and older 23% · Women 55% · Also on Medicaid 71% · Health risk score 2.63. Sicker patients than 9 in 10 peers; the typical interventional cardiology clinician is at 1.7.
Conditions among them: High blood pressure 75% · Diabetes 63% · Coronary heart disease 59% · Heart failure 50% · Chronic kidney disease 48% · Depression 36% · Atrial fibrillation 35% · COPD 33% · Dementia 31% · Stroke 18% · Cancer 17%.
The office billed $426,733, Medicare allowed $177,707 and paid $139,566; for 2,528 services of 52 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,273 | 2,528 | 76 | 2.63 | $426,733 | $139,566 |
| 2023 | 1,228 | 2,027 | 76 | 3.04 | $235,081 | $79,537 |
| 2022 | 337 | 1,032 | 77 | 2.60 | $217,930 | $77,993 |
| 2021 | 167 | 798 | 75 | 3.56 | $219,005 | $79,709 |
| 2020 | 533 | 1,271 | 76 | 3.36 | $265,969 | $113,959 |
| 2019 | 725 | 1,597 | 76 | 2.69 | $389,708 | $131,559 |
| 2018 | 1,618 | 2,847 | 75 | 1.93 | $520,488 | $148,214 |
| 2017 | 1,727 | 2,870 | 75 | 1.96 | $452,976 | $124,673 |
| 2016 | 913 | 1,569 | 75 | 1.88 | $240,843 | $70,510 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 361 | $21,977 | $57 |
| Return visit (30+ min) | 55 | $13,682 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $10,168 | $100 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 908 | $7,661 | $7 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,504 | $145 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 19 | $3,140 | $165 |
| New patient visit (45+ min) | 17 | $2,288 | $135 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 29 | $378 | $12 |
2022: 16 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 64 | $17,855 | $86 |
| Critical care, first 30-74 minutes | 22 | $11,299 | $182 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 49 | $8,593 | $168 |
| Return visit (30+ min) | 36 | $8,144 | $103 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 127 | $7,819 | $61 |
| Long return visit (40+ min) | 17 | $4,841 | $151 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 14 | $2,621 | $187 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 11 | $1,992 | $181 |
| New patient visit (45+ min) | 11 | $1,355 | $123 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 137 | $1,317 | $7 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 16 | $1,075 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 30 | $461 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 21 | $395 | $17 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 16 | $182 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $163 | $13 |
| Ultrasonic guidance for blood vessel access | 12 | $141 | $12 |
2021: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 70 | $13,592 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $12,667 | $174 |
| Critical care, first 30-74 minutes | 22 | $10,221 | $189 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 27 | $5,174 | $192 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 75 | $5,109 | $62 |
| Long return visit (40+ min) | 22 | $4,572 | $158 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 19 | $4,042 | $202 |
| Telephone medical discussion with physician, 11-20 minutes | 27 | $3,407 | $71 |
| Return visit (30+ min) | 14 | $2,154 | $98 |
| Ultrasonic guidance for blood vessel access | 26 | $335 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 27 | $324 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 17 | $254 | $13 |
2020: 17 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 118 | $21,765 | $174 |
| Critical care, first 30-74 minutes | 52 | $21,617 | $193 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 109 | $17,561 | $91 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 165 | $11,510 | $64 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 49 | $8,701 | $178 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 19 | $4,076 | $204 |
| Short return visit (20+ min) | 39 | $3,631 | $57 |
| Ultrasound of both sides of head and neck blood flow | 12 | $2,177 | $181 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 195 | $1,942 | $7 |
| New patient visit (30+ min) | 16 | $1,455 | $91 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 13 | $910 | $70 |
| Telephone medical discussion with physician, 5-10 minutes | 17 | $834 | $42 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 30 | $356 | $11 |
| Ultrasonic guidance for blood vessel access | 26 | $354 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $295 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 13 | $256 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $171 | $13 |
2019: 19 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 135 | $25,232 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 113 | $20,647 | $90 |
| Critical care, first 30-74 minutes | 42 | $17,889 | $190 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 178 | $11,303 | $61 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 59 | $11,283 | $191 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 32 | $6,878 | $191 |
| Short return visit (20+ min) | 31 | $2,433 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 316 | $2,347 | $6 |
| Return visit (30+ min) | 49 | $2,273 | $45 |
| New patient visit (30+ min) | 16 | $1,536 | $96 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 19 | $1,273 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $942 | $63 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 12 | $827 | $69 |
| Ultrasonic guidance for blood vessel access | 40 | $562 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 45 | $553 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 36 | $460 | $12 |
| Ultrasound of heart, follow-up | 12 | $276 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 12 | $232 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $156 | $13 |
2018: 26 services
| Return visit (30+ min) | 211 | $24,695 | $81 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 386 | $23,582 | $59 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 27 | $14,551 | $404 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $8,482 | $166 |
| New patient visit (60+ min) | 50 | $7,900 | $158 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 970 | $7,570 | $7 |
| New patient visit (45+ min) | 50 | $6,465 | $129 |
| Ultrasound of both sides of head and neck blood flow | 32 | $5,532 | $173 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 41 | $4,971 | $84 |
| Critical care, first 30-74 minutes | 21 | $4,659 | $179 |
| Long return visit (40+ min) | 42 | $4,449 | $97 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 21 | $3,215 | $153 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $2,127 | $177 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 110 | $1,778 | $14 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 14 | $1,742 | $116 |
| Ultrasound of leg arteries at rest and after exercise | 12 | $1,653 | $138 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,530 | $102 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 26 | $1,430 | $23 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 17 | $1,303 | $77 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 15 | $1,240 | $73 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 16 | $1,113 | $25 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 33 | $350 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 49 | $314 | $6 |
| External ekg recording for more than 48 hours up to 21 days | 11 | $242 | $22 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 11 | $227 | $21 |
| Ultrasonic guidance for blood vessel access | 18 | $206 | $11 |
2017: 22 services
| Return visit (30+ min) | 180 | $18,025 | $77 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 358 | $17,866 | $49 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 24 | $11,562 | $385 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 65 | $10,929 | $85 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,119 | $8,718 | $7 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 49 | $8,589 | $168 |
| Long return visit (40+ min) | 51 | $6,653 | $119 |
| New patient visit (45+ min) | 49 | $6,204 | $127 |
| New patient visit (60+ min) | 37 | $6,181 | $167 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 24 | $3,777 | $157 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 33 | $3,350 | $102 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 120 | $1,663 | $14 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 21 | $1,600 | $76 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 15 | $1,128 | $75 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 15 | $691 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 11 | $538 | $26 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 39 | $404 | $10 |
| Ultrasound of heart, follow-up | 13 | $280 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 41 | $262 | $6 |
| Ultrasonic guidance for blood vessel access | 15 | $180 | $12 |
| Insertion of needle into vein for collection of blood sample | 42 | $165 | $3 |
| Electrocardiogram, routine ecg with 12 leads; interpretation and report only, performed as a screening for the initial preventive physical examination | 11 | $51 | $5 |
2016: 11 services
| Return visit (30+ min) | 167 | $19,663 | $89 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 220 | $11,334 | $52 |
| New patient visit (45+ min) | 47 | $6,202 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $5,854 | $84 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 47 | $5,252 | $107 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 551 | $4,623 | $7 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 15 | $2,620 | $175 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 15 | $1,210 | $81 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 71 | $1,034 | $14 |
| Insertion of needle into vein for collection of blood sample | 46 | $171 | $3 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 24 | $147 | $6 |
Medicaid work
$59,182 in 2024
Medicaid paid $59,182 for 3,634 billed services this clinician did in 2024, up to 243 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 422 | $31,685 |
| Return visit (30+ min) | 438 | $12,610 |
| New patient visit (45+ min) | 191 | $6,329 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 885 | $5,041 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 259 | $3,518 |
| Current tobacco smoker (CAD, CAP, COPD, PV) (DM) | 24 | $0 |
| TOBACCO NON-USER | 238 | $0 |
| Medication list documented in medical record (COA) | 258 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 258 | $0 |
| BODY MASS INDEX DOCD | 271 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 196 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 175 | $0 |
| 2024 | 3,634 | 13 | 243 | $59,182 |
| 2023 | 4,817 | 13 | 271 | $57,652 |
| 2022 | 840 | 11 | 72 | $7,575 |
| 2021 | 60 | 2 | 20 | $3,297 |
| 2020 | 453 | 5 | 77 | $16,158 |
| 2019 | 536 | 4 | 153 | $11,026 |
| 2018 | 1,202 | 4 | 171 | $8,254 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 413 | $28,179 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,570 | $11,101 |
| Return visit (30+ min) | 346 | $8,163 |
| New patient visit (45+ min) | 146 | $7,158 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 188 | $3,052 |
| TOBACCO NON-USER | 383 | $0 |
| Medication list documented in medical record (COA) | 419 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 419 | $0 |
| BODY MASS INDEX DOCD | 291 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 288 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 27 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 285 | $0 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 65 | $3,396 |
| Return visit (30+ min) | 132 | $2,033 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 63 | $1,131 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 86 | $751 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 26 | $265 |
| TOBACCO NON-USER | 110 | $0 |
| Medication list documented in medical record (COA) | 125 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 125 | $0 |
| BODY MASS INDEX DOCD | 26 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 27 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 55 | $0 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 48 | $2,673 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $624 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 173 | $8,747 |
| 1ST HOSP IP/OBS HIGH 75 | 77 | $4,101 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 35 | $2,280 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 146 | $719 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 22 | $311 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 154 | $6,033 |
| 1ST HOSP IP/OBS HIGH 75 | 66 | $3,165 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 27 | $915 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 289 | $914 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,030 | $3,763 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 128 | $3,270 |
| Return visit (30+ min) | 31 | $1,125 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 13 | $96 |
Drugs they prescribed that Part D paid
$565,293
Pharmacies billed $565,293 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 4,480) in 2024. At or below the middle of the specialty; the typical interventional cardiology clinician is at 0%.
3,688 generic and 792 brand-name prescriptions · $565,293 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 181 | $134,946 | $746 |
| Entresto | 182 | $131,541 | $723 |
| Jardiance | 71 | $46,590 | $656 |
| Farxiga | 46 | $35,063 | $762 |
| Brilinta | 64 | $33,795 | $528 |
See all 61 drugs
| Eliquis | 181 | $134,946 | $746 |
| Entresto | 182 | $131,541 | $723 |
| Jardiance | 71 | $46,590 | $656 |
| Farxiga | 46 | $35,063 | $762 |
| Brilinta | 64 | $33,795 | $528 |
| Xarelto | 34 | $33,610 | $989 |
| Repatha Sureclick | 47 | $32,088 | $683 |
| Multaq | 26 | $19,173 | $737 |
| Repatha | 11 | $9,951 | $905 |
| Icosapent Ethyl | 42 | $9,408 | $224 |
| Clonidine | 43 | $5,606 | $130 |
| Vascepa | 21 | $5,261 | $251 |
| Metoprolol | 557 | $4,850 | $9 |
| Edarbi | 19 | $4,545 | $239 |
| Nifedipine Er | 185 | $3,670 | $20 |
| Rosuvastatin | 321 | $2,971 | $9 |
| Atorvastatin | 306 | $1,958 | $6 |
| Losartan | 279 | $1,833 | $7 |
| Ezetimibe | 90 | $1,597 | $18 |
| Ranolazine Er | 24 | $1,187 | $49 |
| Verapamil Er | 17 | $1,033 | $61 |
| Losartan-Hydrochlorothiazide | 87 | $789 | $9 |
| Diltiazem 24hr Er (Cd) | 26 | $706 | $27 |
| Carvedilol | 115 | $668 | $6 |
| Omega-3 Acid Ethyl Esters | 31 | $655 | $21 |
| Amiodarone | 54 | $575 | $11 |
| Potassium Chloride | 42 | $519 | $12 |
| Spironolactone | 99 | $483 | $5 |
| Fenofibrate | 19 | $465 | $24 |
| Lisinopril | 79 | $445 | $6 |
| Spironolactone-Hctz | 13 | $414 | $32 |
| Olmesartan Medoxomil | 37 | $411 | $11 |
| Nitroglycerin | 61 | $379 | $6 |
| Valsartan-Hydrochlorothiazide | 15 | $377 | $25 |
| Clopidogrel | 57 | $372 | $7 |
| Furosemide | 121 | $350 | $3 |
| Amlodipine Besylate | 190 | $329 | $2 |
| Sotalol | 18 | $326 | $18 |
| Chlorthalidone | 44 | $315 | $7 |
| Valsartan | 38 | $306 | $8 |
| Metolazone | 17 | $286 | $17 |
| Doxazosin Mesylate | 44 | $276 | $6 |
| Telmisartan | 12 | $275 | $23 |
| Atenolol | 78 | $259 | $3 |
| Pantoprazole | 26 | $255 | $10 |
| Isosorbide Mononitrate Er | 48 | $237 | $5 |
| Pravastatin | 48 | $231 | $5 |
| Bumetanide | 15 | $217 | $14 |
| Olmesartan-Hydrochlorothiazide | 23 | $187 | $8 |
| Digoxin | 17 | $186 | $11 |
| Esomeprazole Magnesium | 13 | $185 | $14 |
| Gemfibrozil | 16 | $179 | $11 |
| Amlodipine-Valsartan | 14 | $144 | $10 |
| Sertraline | 29 | $142 | $5 |
| Hydralazine | 17 | $132 | $8 |
| Propranolol Hcl Er | 12 | $124 | $10 |
| Benazepril | 11 | $84 | $8 |
| Gabapentin | 11 | $61 | $6 |
| Hydrochlorothiazide | 55 | $56 | $1 |
| Lisinopril-Hydrochlorothiazide | 29 | $49 | $2 |
| Bisoprolol | 13 | $46 | $4 |
Year by year
| 2024 | 4,480 | 426 | 0% (0) | 18% | $565,293 |
| 2023 | 2,233 | 184 | 0% (0) | 18% | $317,447 |
| 2022 | 1,498 | 204 | 0% (0) | 16% | $200,037 |
| 2021 | 2,337 | 278 | 0% (0) | 14% | $233,729 |
| 2020 | 1,803 | 264 | 0% (0) | 13% | $138,894 |
| 2019 | 1,840 | 347 | 0% (0) | 15% | $132,811 |
| 2018 | 2,648 | 369 | 0% (0) | 16% | $212,344 |
| 2017 | 2,086 | 307 | 0% (0) | 24% | $159,262 |
| 2016 | 902 | 198 | 0% (0) | 24% | $69,018 |
| 2015 | 55 | 13 | 0% (0) | 58% | $20,710 |
| 2014 | 213 | 23 | 0% (0) | 26% | $10,946 |
| 2013 | 346 | 21 | 0% (0) | 32% | $21,150 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 41 drugs
| Eliquis | 101 | $69,566 | $689 |
| Entresto | 93 | $68,955 | $741 |
| Farxiga | 38 | $28,217 | $743 |
| Brilinta | 24 | $24,320 | $1,013 |
| Repatha Sureclick | 27 | $21,359 | $791 |
| Xarelto | 21 | $20,977 | $999 |
| Multaq | 13 | $14,204 | $1,093 |
| Vascepa | 19 | $6,567 | $346 |
| Icosapent Ethyl | 21 | $6,312 | $301 |
| Metoprolol | 275 | $4,855 | $18 |
| Nifedipine Er | 100 | $4,449 | $44 |
| Rosuvastatin | 136 | $4,266 | $31 |
| Atorvastatin | 220 | $3,489 | $16 |
| Losartan | 188 | $2,624 | $14 |
| Clonidine | 30 | $1,974 | $66 |
| Carvedilol | 100 | $1,413 | $14 |
| Ezetimibe | 22 | $1,328 | $60 |
| Diltiazem 24hr Er (Cd) | 25 | $1,204 | $48 |
| Omega-3 Acid Ethyl Esters | 12 | $1,137 | $95 |
| Amiodarone | 12 | $1,126 | $94 |
| Lisinopril | 73 | $813 | $11 |
| Verapamil Sr | 12 | $729 | $61 |
| Amlodipine Besylate | 83 | $719 | $9 |
| Nitroglycerin | 44 | $631 | $14 |
| Doxazosin Mesylate | 17 | $568 | $33 |
| Losartan-Hydrochlorothiazide | 38 | $552 | $15 |
| Spironolactone | 68 | $531 | $8 |
| Chlorthalidone | 22 | $503 | $23 |
| Potassium Chloride | 17 | $434 | $26 |
| Isosorbide Mononitrate Er | 28 | $367 | $13 |
| Sotalol | 12 | $329 | $27 |
| Furosemide | 43 | $264 | $6 |
| Pantoprazole | 19 | $240 | $13 |
| Cartia Xt | 14 | $214 | $15 |
| Pravastatin | 19 | $197 | $10 |
| Clopidogrel | 18 | $190 | $11 |
| Diltiazem | 15 | $184 | $12 |
| Atenolol | 17 | $181 | $11 |
| Lisinopril-Hydrochlorothiazide | 23 | $154 | $7 |
| Triamterene-Hydrochlorothiazid | 19 | $119 | $6 |
| Hydrochlorothiazide | 12 | $65 | $5 |
2022: 27 drugs
| Eliquis | 78 | $55,628 | $713 |
| Brilinta | 39 | $28,888 | $741 |
| Entresto | 28 | $25,873 | $924 |
| Xarelto | 18 | $17,306 | $961 |
| Diovan | 12 | $12,475 | $1,040 |
| Multaq | 12 | $12,448 | $1,037 |
| Metoprolol | 221 | $4,026 | $18 |
| Nifedipine Er | 79 | $3,673 | $46 |
| Rosuvastatin | 57 | $2,518 | $44 |
| Ezetimibe | 17 | $2,448 | $144 |
| Atorvastatin | 156 | $1,871 | $12 |
| Amiodarone | 15 | $1,812 | $121 |
| Diltiazem 24hr Er (Cd) | 31 | $1,524 | $49 |
| Chlorthalidone | 32 | $1,203 | $38 |
| Losartan | 112 | $1,121 | $10 |
| Clonidine | 18 | $879 | $49 |
| Amlodipine Besylate | 82 | $789 | $10 |
| Losartan-Hydrochlorothiazide | 27 | $601 | $22 |
| Lisinopril | 86 | $598 | $7 |
| Carvedilol | 48 | $500 | $10 |
| Valsartan | 15 | $380 | $25 |
| Furosemide | 38 | $270 | $7 |
| Potassium Chloride | 17 | $266 | $16 |
| Spironolactone | 34 | $241 | $7 |
| Nitroglycerin | 12 | $226 | $19 |
| Atenolol | 14 | $114 | $8 |
| Hydrochlorothiazide | 19 | $38 | $2 |
2021: 28 drugs
| Eliquis | 118 | $78,961 | $669 |
| Brilinta | 73 | $37,503 | $514 |
| Xarelto | 29 | $25,594 | $883 |
| Entresto | 16 | $10,873 | $680 |
| Nifedipine Er | 139 | $9,231 | $66 |
| Multaq | 12 | $8,642 | $720 |
| Metoprolol | 338 | $8,400 | $25 |
| Rosuvastatin | 87 | $4,219 | $48 |
| Atorvastatin | 218 | $3,576 | $16 |
| Chlorthalidone | 62 | $2,426 | $39 |
| Valsartan | 35 | $1,930 | $55 |
| Amiodarone | 19 | $1,872 | $99 |
| Losartan-Hydrochlorothiazide | 61 | $1,817 | $30 |
| Losartan | 137 | $1,581 | $12 |
| Carvedilol | 159 | $1,549 | $10 |
| Diltiazem 24hr Er (Cd) | 28 | $1,091 | $39 |
| Amlodipine Besylate | 140 | $974 | $7 |
| Hydralazine | 37 | $789 | $21 |
| Lisinopril | 158 | $763 | $5 |
| Furosemide | 90 | $623 | $7 |
| Ezetimibe | 13 | $580 | $45 |
| Benazepril | 23 | $399 | $17 |
| Lisinopril-Hydrochlorothiazide | 41 | $358 | $9 |
| Clopidogrel | 25 | $320 | $13 |
| Nitroglycerin | 19 | $316 | $17 |
| Atenolol | 20 | $224 | $11 |
| Spironolactone | 20 | $150 | $7 |
| Hydrochlorothiazide | 33 | $139 | $4 |
2020: 27 drugs
| Eliquis | 61 | $39,751 | $652 |
| Xarelto | 38 | $26,753 | $704 |
| Brilinta | 33 | $16,103 | $488 |
| Entresto | 18 | $10,861 | $603 |
| Nifedipine Er | 131 | $7,700 | $59 |
| Metoprolol | 350 | $6,570 | $19 |
| Atorvastatin | 184 | $2,486 | $14 |
| Chlorthalidone | 64 | $2,465 | $39 |
| Rosuvastatin | 39 | $1,823 | $47 |
| Losartan-Hydrochlorothiazide | 21 | $1,428 | $68 |
| Losartan | 118 | $1,193 | $10 |
| Carvedilol | 72 | $689 | $10 |
| Valsartan | 17 | $688 | $40 |
| Lisinopril | 136 | $646 | $5 |
| Diltiazem 24hr Er (Cd) | 20 | $610 | $31 |
| Amlodipine Besylate | 103 | $534 | $5 |
| Nitroglycerin | 23 | $528 | $23 |
| Clopidogrel | 23 | $502 | $22 |
| Hydralazine | 24 | $471 | $20 |
| Potassium Chloride | 22 | $459 | $21 |
| Benazepril | 31 | $409 | $13 |
| Furosemide | 65 | $388 | $6 |
| Felodipine Er | 14 | $355 | $25 |
| Lisinopril-Hydrochlorothiazide | 21 | $170 | $8 |
| Enalapril Maleate | 12 | $159 | $13 |
| Spironolactone | 14 | $119 | $9 |
| Hydrochlorothiazide | 12 | $108 | $9 |
2019: 29 drugs
| Xarelto | 101 | $63,556 | $629 |
| Eliquis | 41 | $22,382 | $546 |
| Brilinta | 21 | $10,207 | $486 |
| Metoprolol | 247 | $8,341 | $34 |
| Atorvastatin | 267 | $5,056 | $19 |
| Ezetimibe | 65 | $2,968 | $46 |
| Nifedipine Er | 43 | $2,390 | $56 |
| Chlorthalidone | 43 | $1,833 | $43 |
| Rosuvastatin | 34 | $1,454 | $43 |
| Losartan | 116 | $1,098 | $9 |
| Clopidogrel | 63 | $1,006 | $16 |
| Potassium Chloride | 38 | $912 | $24 |
| Lisinopril | 147 | $819 | $6 |
| Carvedilol | 52 | $630 | $12 |
| Amlodipine Besylate | 81 | $613 | $8 |
| Furosemide | 80 | $557 | $7 |
| Hydralazine | 12 | $440 | $37 |
| Lisinopril-Hydrochlorothiazide | 54 | $393 | $7 |
| Nitroglycerin | 24 | $347 | $14 |
| Toprol Xl | 13 | $323 | $25 |
| Diltiazem 24hr Er (Cd) | 16 | $323 | $20 |
| Amiodarone | 19 | $273 | $14 |
| Spironolactone | 39 | $254 | $7 |
| Simvastatin | 12 | $204 | $17 |
| Sotalol | 15 | $191 | $13 |
| Atenolol | 23 | $189 | $8 |
| Losartan-Hydrochlorothiazide | 18 | $170 | $9 |
| Enalapril Maleate | 12 | $107 | $9 |
| Hydrochlorothiazide | 26 | $104 | $4 |
2018: 37 drugs
| Xarelto | 130 | $88,958 | $684 |
| Eliquis | 54 | $32,085 | $594 |
| Metoprolol | 354 | $16,712 | $47 |
| Brilinta | 21 | $11,774 | $561 |
| Atorvastatin | 420 | $8,654 | $21 |
| Ezetimibe | 77 | $7,200 | $94 |
| Diltiazem 24hr Er (Cd) | 19 | $6,328 | $333 |
| Clopidogrel | 109 | $2,199 | $20 |
| Lisinopril | 223 | $1,623 | $7 |
| Isosorbide Mononitrate Er | 61 | $1,473 | $24 |
| Potassium Chloride | 44 | $1,467 | $33 |
| Losartan | 147 | $1,403 | $10 |
| Rosuvastatin | 35 | $1,396 | $40 |
| Chlorthalidone | 27 | $1,283 | $48 |
| Diltiazem 24hr Er | 21 | $1,175 | $56 |
| Carvedilol | 97 | $1,087 | $11 |
| Furosemide | 134 | $1,008 | $8 |
| Digoxin | 13 | $950 | $73 |
| Cartia Xt | 31 | $911 | $29 |
| Toprol Xl | 24 | $791 | $33 |
| Sotalol | 24 | $732 | $31 |
| Nitroglycerin | 37 | $686 | $19 |
| Bumetanide | 16 | $630 | $39 |
| Amlodipine Besylate | 77 | $587 | $8 |
| Spironolactone | 48 | $428 | $9 |
| Simvastatin | 26 | $356 | $14 |
| Valsartan | 14 | $327 | $23 |
| Lisinopril-Hydrochlorothiazide | 37 | $309 | $8 |
| Losartan-Hydrochlorothiazide | 27 | $271 | $10 |
| Pantoprazole | 23 | $242 | $11 |
| Atenolol | 30 | $238 | $8 |
| Metoprolol | 20 | $233 | $12 |
| Amiodarone | 21 | $223 | $11 |
| Triamterene-Hydrochlorothiazid | 25 | $201 | $8 |
| Hydralazine | 11 | $145 | $13 |
| Gemfibrozil | 13 | $89 | $7 |
| Hydrochlorothiazide | 25 | $81 | $3 |
2017: 33 drugs
| Xarelto | 106 | $70,442 | $665 |
| Metoprolol | 273 | $11,876 | $44 |
| Eliquis | 14 | $9,742 | $696 |
| Ranexa | 11 | $9,471 | $861 |
| Brilinta | 15 | $6,778 | $452 |
| Atorvastatin | 324 | $6,608 | $20 |
| Ezetimibe | 26 | $5,351 | $206 |
| Diltiazem 24hr Er | 27 | $2,943 | $109 |
| Rosuvastatin | 29 | $2,201 | $76 |
| Potassium Chloride | 45 | $1,970 | $44 |
| Isosorbide Mononitrate Er | 69 | $1,857 | $27 |
| Clopidogrel | 78 | $1,418 | $18 |
| Clonidine | 12 | $1,195 | $100 |
| Lisinopril | 148 | $1,152 | $8 |
| Nitroglycerin | 50 | $1,020 | $20 |
| Carvedilol | 92 | $929 | $10 |
| Furosemide | 111 | $854 | $8 |
| Losartan | 104 | $757 | $7 |
| Toprol Xl | 25 | $707 | $28 |
| Valsartan | 18 | $667 | $37 |
| Metolazone | 15 | $617 | $41 |
| Cartia Xt | 18 | $550 | $31 |
| Simvastatin | 49 | $534 | $11 |
| Digoxin | 11 | $452 | $41 |
| Amlodipine Besylate | 68 | $435 | $6 |
| Metoprolol | 40 | $371 | $9 |
| Losartan-Hydrochlorothiazide | 22 | $336 | $15 |
| Amiodarone | 20 | $268 | $13 |
| Spironolactone | 20 | $214 | $11 |
| Triamterene-Hydrochlorothiazid | 18 | $212 | $12 |
| Pravastatin | 12 | $174 | $15 |
| Atenolol | 32 | $155 | $5 |
| Hydrochlorothiazide | 21 | $95 | $5 |
2016: 21 drugs
| Xarelto | 40 | $21,353 | $534 |
| Crestor | 13 | $5,716 | $440 |
| Ranexa | 14 | $5,526 | $395 |
| Atorvastatin | 123 | $2,777 | $23 |
| Metoprolol | 97 | $2,702 | $28 |
| Valsartan | 15 | $825 | $55 |
| Lisinopril | 80 | $751 | $9 |
| Carvedilol | 65 | $594 | $9 |
| Metoprolol | 39 | $404 | $10 |
| Cartia Xt | 16 | $402 | $25 |
| Isosorbide Mononitrate Er | 26 | $391 | $15 |
| Furosemide | 54 | $377 | $7 |
| Losartan | 32 | $324 | $10 |
| Amlodipine Besylate | 36 | $303 | $8 |
| Diltiazem 24hr Er | 12 | $289 | $24 |
| Potassium Chloride | 13 | $273 | $21 |
| Clopidogrel | 16 | $273 | $17 |
| Simvastatin | 16 | $183 | $11 |
| Pravastatin | 12 | $178 | $15 |
| Atenolol | 11 | $83 | $8 |
| Hydrochlorothiazide | 12 | $38 | $3 |
2014: 7 drugs
| Metoprolol | 30 | $1,404 | $47 |
| Atorvastatin | 28 | $351 | $13 |
| Clopidogrel | 24 | $156 | $7 |
| Lisinopril | 24 | $106 | $4 |
| Isosorbide Mononitrate Er | 13 | $104 | $8 |
| Lisinopril-Hydrochlorothiazide | 12 | $95 | $8 |
| Simvastatin | 12 | $78 | $7 |
2013: 7 drugs
| Metoprolol | 54 | $1,569 | $29 |
| Atorvastatin | 45 | $875 | $19 |
| Lisinopril | 48 | $397 | $8 |
| Hydralazine | 11 | $302 | $27 |
| Carvedilol | 24 | $284 | $12 |
| Amlodipine Besylate | 17 | $193 | $11 |
| Losartan | 16 | $181 | $11 |
Money from drug and device companies
$66 in 2024
| 2024 | 2 | 3 | None | $66 |
| 2023 | 2 | 3 | None | $196 |
| 2022 | 1 | 1 | None | $14 |
| 2021 | 1 | 1 | None | $27 |
| 2020 | 6 | 7 | None | $124 |
| 2019 | 6 | 14 | None | $356 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Lux-Dx Insertable Cardiac Monitor | $48 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $17 | 1 payment
|
See all 3 published payments
| Boston Scientific | Meals · 2024-09-20 | Emblem Mri S-Icd | $24 |
| Boston Scientific | Meals · 2024-08-21 | Lux-Dx Insertable Cardiac Monitor | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2024-03-04 | Lifevest | $17 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $196
| Boston Scientific | Avvigo Guidance System | $169 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $27 | 1 payment
|
2022: $14
| AstraZeneca Pharmaceuticals LP | Farxiga | $14 | 1 payment
|
2021: $27
| Pfizer | Eliquis | $27 | 1 payment
|
2020: $124
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $30 | 2 payments
|
| Abbott Laboratories | Cardiomems Hf System | $23 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $19 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Adempas | $19 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $18 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $15 | 1 payment
|
2019: $356
| AstraZeneca Pharmaceuticals LP | Brilinta | $119 | 2 payments
|
| Amgen | Corlanor | $118 | 5 payments
|
| Alnylam Pharmaceuticals | Onpattro | $40 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $36 | 2 payments
|
| Terumo Medical | Glidesheath | $27 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $15 | 1 payment
|
Professional record
- NPI
- 1417117771
- Licence
- WA MD60640196Washington MD.MD.60640196: Expired
- Trained
- Georgetown University School of Medicine, 2008 · 18 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- WA 2058266
- Taxonomy
- Cardiology (207RC0000X); Federal specialty code 207RI0011X (207RI0011X)
- Mailing address
- 281 E Colorado Blvd # 751, Pasadena, CA, 91101
- NPI first listed
- 2008-06-11
- NPI last updated
- 2021-05-05
- NPI record certified
- 2021-05-05
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 50 Bellefontaine St Ste 301, Pasadena, CA, 91105